Edesa Biotech (EDSA) Return on Equity [ROE] (2015 - 2026)
Edesa Biotech's Return on Equity [ROE] came in at -103.03% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 61.24 percentage points from -41.78% a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Edesa Biotech's Return on Equity [ROE] was -99.57%, up 37.08 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +7.50 percentage points (FY2020 to FY2025).
- Going back by fiscal year, Return on Equity [ROE] was -136.66% in FY2024 (-34.77 pp), -101.88% in FY2023 (+54.46 pp), -156.34% in FY2022 (-20.80 pp) and -135.54% in FY2021 (-28.47 pp).
- The fiscal Q3 2026 figure represents the lowest quarterly Return on Equity [ROE] since fiscal Q1 2025.
- Year-over-year, Return on Equity [ROE] increased in four of the last seven quarters, with an average year-over-year change of +40.98 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q1 2026 (a gain of 241.08 percentage points), and the weakest in fiscal Q1 2025 (a drop of 179.43 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Edesa Biotech | 40.56 Mn | 40.56 Mn | - | -103.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -103.03% |
| Dec 31, 2025 | -59.91% |
| Sep 30, 2025 | -56.17% |
| Jun 30, 2025 | -41.78% |
| Mar 31, 2025 | -68.72% |
| Dec 31, 2024 | -300.99% |
| Sep 30, 2024 | -259.39% |
| Jun 30, 2024 | -195.98% |
| Mar 31, 2024 | -144.82% |
| Dec 31, 2023 | -121.55% |
| Sep 30, 2023 | -112.34% |
| Jun 30, 2023 | -112.31% |
| Mar 31, 2023 | -137.64% |
| Dec 31, 2022 | -157.63% |
| Sep 30, 2022 | -172.65% |
| Jun 30, 2022 | -133.03% |
| Mar 31, 2022 | -131.80% |
| Dec 31, 2021 | -134.37% |
| Sep 30, 2021 | -92.29% |
| Jun 30, 2021 | -66.38% |
API Access
Edesa Biotech Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();